Silvassa manufacturing expansion completed

Date: 23-10-2026 The Manager – Lis(cid:415)ng Department BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 501261 Subject: In(cid:415)ma(cid:415)on (cid:415)tled “Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its interna(cid:415)onal footprint across the United States and South America” Dear Sir/Madam, Pursuant to Regula(cid:415)on 30 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015, please find a(cid:425)ached herewith the in(cid:415)ma(cid:415)on (cid:415)tled “Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its interna(cid:415)onal footprint across the United States and South America”. Thanking you, Yours faithfully, For Lord's Mark Industries Limited (Formerly known as Lords Mark India Limited and Kratos Energy & Infrastructure Limited) Sachidanand Hariram Upadhyay Managing Director DIN: 01631728 Lord’s Mark Industries Limited Becomes Asia’s First Company to Secure US FDA Registra(cid:415)on for 200+ Surgical and Hygiene Products; US Exports to Begin in December  Silvassa manufacturing expansion completed ahead of schedule as the company prepares to expand its interna(cid:415)onal footprint across the United States and South America Lord’s Mark Industries Limited has achieved a significant milestone in healthcare manufacturing, becoming, according to the company, Asia’s first company to secure US FDA registra(cid:415)on for more than 200 surgical, medical-care and hygiene products. The company plans to commence exports to the United States in December 2026, marking a major step in its interna(cid:415)onal expansion strategy. With its Silvassa manufacturing capacity expansion completed ahead of schedule, Lord’s Mark Industries is also preparing to explore opportuni(cid:415)es across South America, subject to applicable country-specific regulatory requirements. The development comes as the company completes its manufacturing capacity expansion at Silvassa ahead of schedule, strengthening its produc(cid:415)on readiness for interna(cid:415)onal markets. With a diversified por(cid:414)olio spanning orthopaedic supports, rehabilita(cid:415)on aids, mobility solu(cid:415)ons, hygiene products and medical-care essen(cid:415)als, Lord’s Mark Industries aims to build a scalable export business from India. The product por(cid:414)olio includes Lords Ac(cid:415)veguard cervical-thoracic braces, so(cid:332) cervical collars, cervical and lumbar supports, abdominal belts, rib belts, chest binders, clavicle braces, shoulder immobilisers, arm slings, wrist and forearm splints, finger splints, thumb spica splints, elbow supports, tennis elbow braces, knee caps, knee immobilisers, hinged knee braces, patellar supports, ankle braces, ankle binders, foot-drop splints and bunion correctors. The range further includes compression stockings, varicose-vein stockings, hernia belts, scrotal supports, pregnancy supports, pelvic binders, cervical trac(cid:415)on kits, trac(cid:415)on belts, walking s(cid:415)cks, walkers, wheelchairs, commode chairs, orthopaedic cushions, heel cups, silicone insoles and posture correctors. The hygiene and medical-care range includes Lord’s Joywipes disinfectant and cleansing wipes, Lords Magic Elas(cid:415)c Adhesive Bandages, IV Cannula Fixator Elas(cid:415)c Adhesive Bandages, Lords Wonder Co(cid:425)on Crepe Bandages, Lords Confidence adult diapers and Safelite sanitary napkins. The por(cid:414)olio also features disposable hot and cold gel packs and medical tourniquets. Together, these products provide a diversified base across orthopaedic support, rehabilita(cid:415)on, mobility, hygiene and medical-care essen(cid:415)als. The expansion posi(cid:415)ons the company to explore opportuni(cid:415)es in a substan(cid:415)al global healthcare market. According to Mordor Intelligence, the United States general surgical devices market is projected to grow from US$6.69 billion in 2025 to US$9.67 billion by 2031, registering a CAGR of 6.35%. The South American general surgical devices market is projected to increase from US$1.37 billion in 2025 to US$2.19 billion by 2031, at a CAGR of 8.20%. These broader market es(cid:415)mates highlight the poten(cid:415)al opportunity, although the addressable market for the company will depend on individual product categories and applicable regulatory requirements. Commen(cid:415)ng on the development, Dr. Sachidanand Upadhyay, Founder, Managing Director and CEO of Lord’s Mark Industries Limited, said, “This cer(cid:415)fica(cid:415)on proves the strong hold of our regulatory compliance team, our product quality and our vision to make India great. With more than 200 surgical, medical-care and hygiene products listed with the US FDA, we are taking an important step towards expanding our global footprint. The early comple(cid:415)on of our Silvassa manufacturing capacity expansion further strengthens our readiness to serve interna(cid:415)onal markets. Our vision is to establish India as a globally recognised healthcare manufacturing hub and demonstrate the capabili(cid:415)es of Indian industry through quality-driven products and a strong commitment to regulatory compliance.” The company plans to leverage its expanded manufacturing capabili(cid:415)es to pursue partnerships with interna(cid:415)onal distributors, healthcare suppliers and ins(cid:415)tu(cid:415)onal buyers. While the United States will be the immediate export priority, South America offers a poten(cid:415)al avenue for further expansion. Entry into individual markets will be subject to the applicable product-specific registra(cid:415)on, import and distribu(cid:415)on requirements. With its expanded manufacturing capacity and wide-ranging medical-care por(cid:414)olio, Lord’s Mark Industries aims to strengthen its posi(cid:415)on as an Indian healthcare manufacturer with growing interna(cid:415)onal ambi(cid:415)ons, while contribu(cid:415)ng to the broader opportunity for Indian-made medical products in global markets.